跳至主要内容
临床试验/JPRN-UMIN000010668
JPRN-UMIN000010668已完成未知

Examination on mucosal healing in mild to moderate active ulcerative colitis with mesalazine: a multicentre prospective open study - EXACT Study

Dokkyo Medical University0 个研究点目标入组 80 人开始时间: 2013年5月8日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Moderate, severe or fulminating active ulcerative colitis. 2.Use of oral 5-ASAs more than 4g/day within 2 weeks prior to study entry. 3.Introduce or increase the dosage of Steroids (intravenous infusion, oral), biologics or CAP within the last 90 days. 4.Increase the dosage of immunomodulators within the last 90 days. 5.Introduce or increase the treatment in the observation period. 6.Possible or documented pregnancy. 7.Experience of hypersensitivity to mesalazine. 8.Malignant disease or its history. 9.Patients who are considered inappropriate by investigators.

研究者

相似试验